Christopher L. Howard - 04 Aug 2022 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Role: EVP, GC and Secretary
Signature: /s/ Christopher L. Howard
Issuer symbol: ACHC
Transactions as of: 04 Aug 2022
Net transactions value: -$1,374,254
Form type: 4
Filing time: 08 Aug 2022, 18:52:13 UTC
Previous filing: 13 Apr 2022
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACHC	Common Stock	Options Exercise	$311,453	+6,137	+3.7%	$50.75	169,804	04 Aug 2022	Direct
transaction	ACHC	Common Stock	Sale	$688,189	-8,443	-5%	$81.51	161,361	04 Aug 2022	Direct	F1
transaction	ACHC	Common Stock	Sale	$997,517	-12,214	-7.6%	$81.67	149,147	08 Aug 2022	Direct	F2
holding	ACHC	Common Stock						85,613	04 Aug 2022	See Footnote	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACHC	Stock Option	Options Exercise	$0	+6,137		$0.000000^*	0	04 Aug 2022	Common Stock	6,137	$50.75	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.65, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.96, inclusive. The reporting person undertakes to provide to Acadia, any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	Mr. Howard expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
F4	Includes 25,613 shares held by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust, 25,613 shares held by the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust and 34,387 shares held by the reporting person's spouse.